Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
46.07
+0.27 (+0.59%)
Official Closing Price
Updated: 7:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12,054,051
Open
45.97
Bid (Size)
45.85 (100)
Ask (Size)
46.00 (100)
Prev. Close
45.80
Today's Range
45.19 - 46.14
52wk Range
35.12 - 81.44
Shares Outstanding
N/A
Dividend Yield
5.54%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
↗
Today 6:25 EDT
The weight loss drug market is on track to reach almost $100 billion.
Via
The Motley Fool
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
↗
May 08, 2026
As Hims & Hers pivots to branded GLP-1s via a Novo Nordisk deal, all eyes are on the company’s May 11 earnings as investors look for sustained subscriber growth.
Via
MarketBeat
Performance
YTD
-12.1%
-12.1%
1 Month
+22.5%
+22.5%
3 Month
-3.3%
-3.3%
6 Month
+0.9%
+0.9%
1 Year
-29.0%
-29.0%
More News
Read More
Forget Eli Lilly: These 2 Stocks Have More Upside
↗
May 07, 2026
Via
The Motley Fool
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims
↗
May 07, 2026
Via
MarketBeat
My Top Obesity Stock to Buy and Hold
↗
May 07, 2026
Via
The Motley Fool
Record Highs, Punished Results, and One Very Consequential Apple Rumor
↗
May 06, 2026
Via
Chartmill
3 Absurdly Cheap Growth Stocks to Buy in May 2026
↗
May 04, 2026
Via
The Motley Fool
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
↗
May 04, 2026
Via
The Motley Fool
Eli Lilly Just Announced Fantastic News for Shareholders
↗
May 04, 2026
Via
The Motley Fool
Topics
Earnings
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)
↗
May 02, 2026
Via
The Motley Fool
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
↗
May 01, 2026
Via
MarketBeat
Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge
↗
May 01, 2026
Via
MarketBeat
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
↗
April 30, 2026
Via
The Motley Fool
Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So
↗
April 28, 2026
Via
The Motley Fool
Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means
↗
April 28, 2026
Via
MarketBeat
Is This Deal a Game Changer for Novo Nordisk?
↗
April 27, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli Lilly
↗
April 27, 2026
Via
The Motley Fool
This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street
↗
April 26, 2026
Via
The Motley Fool
Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom?
↗
April 25, 2026
Via
The Motley Fool
Why Eli Lilly Stock Flopped on Friday
↗
April 24, 2026
Via
The Motley Fool
Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026)
↗
April 24, 2026
Via
The Motley Fool
Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap?
↗
April 23, 2026
Via
The Motley Fool
The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
April 23, 2026
From
Equity Insider
Via
GlobeNewswire
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
↗
April 23, 2026
Via
The Motley Fool
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program
↗
April 21, 2026
Via
The Motley Fool
Topics
Stocks
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 46.07
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 05/08/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.